Browse studies

Find your next paid study

27,407 recruiting studies available now

Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

The goal of this observational study is to identify the impact of incretin-based obesity medications (e.g., GLP-1 and GLP-1/GIP) on health and economic outcome…

Obesity

Estimated

~$10 – $750

Actual pay is set by the research site.

Indiana UniversityNCT07640139

Phase 4

Kera Sol Post-LASIK: A Benefit Study

Collecting data using Kera Sol tear usage during the initial two-week post-operative period after Laser-Assisted In Situ Keratomileusis (LASIK) has on the sign…

Dry Eye

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Vance Thompson VisionNCT07155070

Phase 4

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.

To learn if OCSCC patients can be safely given methylnaltrexone for 2 weeks before surgery.

Head and Neck Squamous Cell Carcinoma

Estimated

~$25 – $1,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06162377

Phase 2

An Open-Label, Multicenter, Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Extension study to provide ongoing long-term treatment with ASTX727 for participants who were benefitting from ASTX727 treatment in a previous Taiho (formerly …

Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Taiho Oncology, Inc.NCT04093570

100-Year Human Aging Study: Prospective Longitudinal Validation of Multi-System Health Measurements Against Mortality and Aging Outcomes

The 100-Year Human Aging Study is a prospective, pragmatic, observational trial enrolling participants across fixed clinical sites, mobile clinical sites, and …

AgingAging WellAll-Cause Mortality+12 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Longevity Metrics, Inc.NCT07563777

Observational

Safety and Efficacy of NeuroTechR3 System for Upper Extremity Recovery After Stroke

This research aims to understand the feasibility and effectiveness of using the NeuroTechR3 System to improve upper extremity function after stroke.

Stroke

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Brooks RehabilitationNCT07769281

Phase 3

Phase 3 Study of Serine Supplementation to Protect Vision in MacTel

The goal of this clinical trial is to look at the efficacy and safety of giving oral serine (an amino acid) on the progression of structural and functional cha…

Macular Telangiectasia Type 2 (MacTel)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

The Lowy Medical Research Institute LimitedNCT07342439

Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligib…

Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Ascidian Therapeutics, IncNCT06445322

Pharmacogenomics of Age-Specific, Asparaginase-Induced Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia

This pilot trial studies the impact of genetic information on developing liver damage caused by asparaginase in participants with newly diagnosed acute lymphob…

Acute Lymphoblastic Leukemia

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Southern CaliforniaNCT03568266

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1

This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how…

Obesity, MorbidNASH - Nonalcoholic SteatohepatitisChronic Inflammation

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT04232566

Phase 1

A Phase 1/2 Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of ARV-6723 Administered as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

This is a study to evaluate the safety and potential anti-tumor activity of an investigational drug called ARV-6723, in participants with advanced solid tumors…

Advanced Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Arvinas Inc.NCT07749586

The Congenital Dyserythropoietic Anemia Registry (CDAR)

The investigators have created and maintain a comprehensive registry for patients with the diagnosis of Congenital Dyserythropoietic Anemia (CDA) in North Amer…

Congenital Dyserythropoietic Anemia (CDA)

Estimated

~$10 – $675

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT02964494